Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
More News related to BSTE
- Atticus Capital Boosts Stake in Inverness Medical (IMA) to 5.5%
- Piper Jaffray upgrades Biosite Incorporated (BSTE) to Market Perform
- Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
- Largest $ Movers of Note - StreetInsider.com - 05/15/2007
- Inverness Medical Innovations (IMA) Raises Bid for Biosite (BSTE) to $92.50
More News related to CTEC
- Cholestech (CTEC) Receives FDA CLIA Waived Status for New Combined Test Panel
- Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
- StreetInsider.com Unusual 11 Mid-Day Movers 06/04/2007
- Inverness Medical Innovations (IMA) to Acquire Cholestech (CTEC)
- Cholestech (CTEC) Partners with Onsite Health Diagnostics for On-site, Corporate Health Screenings
More News related to IMA
- Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
- ThinkEquity Initiates Coverage on Inverness Medical (IMA) with a Buy
- Alere Introduces Industry's First 12-month Unlimited Health Coaching Program
- Notable Mergers and Acquisitions of the Day 6/5: RTP/ACH/BHP, MGLN, IMA
- Inverness Medical (IMA) Offers to Acquire Outstanding Shares of Concateno plc
Stifel Nicolaus upgrades Inverness Medical Innovations (AMEX: IMA) from Hold to Buy with a $58 price target. The firm said, "We like both the strategic and financial impact of the Cholestech (NASDAQ: CTEC) acquisition that Inverness announced Monday morning. In addition, we have gained greater comfort with the proposed Biosite (Nasdaq: BSTE) deal, and the ability of Inverness to derive significant cost savings from the combined organizations."
Related Categories
UpgradesStocks Mentioned
-92.48
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
